Linda N. Geng

Also affiliated with Stanford Health Care, Stanford Medicine, Stanford University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome”.

Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome

JCI Insight(2022)10.1172/jci.insight.156713

N/A

1.5DataRank · unranked

39 citations

Shu Cao, Alexandra S. Lee, Monali Manohar, Sayantani Sindher, Neera Ahuja +35 more

Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort

Annals of Internal Medicine(2024)10.7326/m24-0737

N/A

1.1DataRank · unranked

47 citations

Linda N. Geng, Caitlin Selvaggi, Tanayott Thaweethai, Peter Chen, Nathan Erdmann +89 more

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

Nature Communications(2024)10.1038/s41467-023-44090-5

N/A

0DataRank · unranked

60 citations

Naresh Doni Jayavelu, Shanshan Liu, Esther Melamed, Carly E. Milliren, Jingjing Qi +95 more

IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition

Nature Communications(2024)10.1038/s41467-023-44211-0

N/A

0DataRank · unranked

28 citations

Kyra Woloszczuk, Jintong Hou, Jennifer Connors, Gina Cusimano, Matthew R. Bell +94 more

Targeting the SARS-CoV-2 reservoir in long COVID

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(24)00769-2

N/A

0DataRank · unranked

56 citations

Soo Aleman, Morgane Bomsel, Petter Brodin, Marcus Buggert, Sara Cherry +31 more

Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort

Journal of Allergy and Clinical Immunology Global(2025)10.1016/j.jacig.2025.100515

N/A

0DataRank · unranked

2 citations

Jingjing Qi, Carly E. Milliren, Al Ozonoff, Shanshan Liu, Ofer Levy +87 more

Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf634

N/A

0DataRank · unranked

1 citations

Haley Hedlin, Jane W. Liang, Blake Shaw, Evan Maestri, Michelle I. Lin +5 more

Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS

Critical Care(2025)10.1186/s13054-025-05596-0

N/A

0DataRank · unranked

1 citations

Harry Pickering, Aartik Sarma, C. Taylor, Meagan M. Jenkins, Fei‐Man Hsu +88 more

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

medRxiv(2025)10.1101/2025.02.12.25322164

N/A

0DataRank · unranked

3 citations

Hady Samaha, S. Wimalasena, Annmarie Hoch, Jeremy P. Gygi, Gisela Gabernet +45 more

Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit

Research Square(2025)10.21203/rs.3.rs-6875205/v1

N/A

0DataRank · unranked

0 citations

Abigail Glascock, Cole Maguire, Hoang Van Phan, Emily Lydon, Carolyn S. Calfee +49 more

Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial

medRxiv(2025)10.64898/2025.12.04.25341650

N/A

0DataRank · unranked

0 citations

Woo Joo Kwon, Hong Zheng, Tyler R. Prestwood, Haley Hedlin, Jane W. Liang +24 more

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19

International Immunopharmacology(2023)10.1016/j.intimp.2023.110966

N/A

0DataRank · unranked

30 citations

Lü Tian, Vincent C. Marconi, Robert W. Shafer, Grace A. McComsey, Mitchell G. Miglis +5 more